Beta-Glucan Market worth $800 million by 2029 - Exclusive Report by MarketsandMarkets™

CHICAGO, April 24, 2024 /PRNewswire/ -- The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarkets™. The growth of the beta-glucan market is being fueled by factors like the growing demand for natural food additives in the food and beverage industry and the increasing utilization of beta-glucan in pharmaceutical tablets and capsules. Additionally, the rising trend of incorporating beta-glucan in cosmetic products to enhance emulsification is contributing to market expansion.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796

Browse in-depth TOC on "Beta-Glucan Market"

70 – Tables

60 – Figures

350 – Pages

By source, the yeast segment is expected to grow at a faster rate during the forecast period 2024-2029.

Yeast has emerged as a leading and rapidly growing source for the beta-glucan market due to its efficiency in producing high-quality beta-glucans at a fast rate. Yeast plays a pivotal role in industrial fermentation processes, contributing to the production of a range of products like bread, beer, and biofuels. Efficient and speedy growth of yeast is essential for large-scale industrial cultivation to meet production requirements. In industrial settings, yeast strains are frequently tailored for rapid growth rates, including the production of beta-glucans, thereby bolstering yeast's potential as a prolific source of beta-glucan, and they have gained significant attention for their health-promoting properties, including immune system modulation and cholesterol-lowering effects. Yeast, particularly species like Saccharomyces cerevisiae, offers several advantages in beta-glucan production, including scalability, consistent quality, and cost-effectiveness. Moreover, advancements in biotechnological processes and genetic engineering have further enhanced yeast's potential as a sustainable and efficient source for beta-glucan production, positioning it at the forefront of the expanding beta-glucan market.

By application dietary supplement segment is expected to grow fastest during the forecast period

Yeast is crucial in industrial fermentation processes, facilitating the production of diverse products such as bread, beer, and biofuels. Rapid and efficient yeast growth is vital for meeting the demands of large-scale industrial production. In these industrial environments, yeast strains are often optimized for fast growth, which includes enhancing the production of beta-glucans, reinforcing yeast's capacity as a significant source of beta-glucan. Swisse Wellness, an Australian health and wellness firm, introduced the Beta-Immune Booster, a dietary supplement featuring beta-glucan derived from the yeast Saccharomyces cerevisiae. Marketed to bolster immune function, the product debuted in 2021 and has garnered favorable feedback from users. This launch highlights the rising interest in and demand for beta-glucan supplements as consumers increasingly turn to natural and potent dietary aids. This trend suggests a promising future for beta-glucan products in the marketplace.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=5191796

The North American market is projected to contribute the largest share for the beta-glucan market

The North American beta-glucan market is driven by its extensive use in various products and their associated health benefits. Key players in this market segment in North America include Merck (US) and Lesaffre (US). Advancements in technology have expanded the applications of beta-glucan in the food & beverage industry, where it is utilized as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents, thereby fostering growth in the region.

In the US, consumer preferences are shifting towards low-calorie and low-fat food options due to increased calorie-consciousness. The rising incidence of obesity and cardiovascular diseases has fueled demand for natural and low-calorie ingredient-based food products. Data from the Centre for Disease Control & Prevention (CDC) and the National Health and Nutrition Examination Survey (2021-2022) indicates that the adult obesity rate has surged to 42.4% in 2020-2021.

The rise in incidences of obesity, heart diseases, diabetes, and other health issues has led to a surge in demand for healthy ingredient-based products manufactured. Consumers in North America are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing body immunity. This, in turn, is projected to drive the growth of the beta-glucan market in this region. The growth of the food industry and the increase in the usage of healthy food ingredients and additives in Canada and Mexico have contributed to the growth of the beta-glucan market in North America. Food manufacturers are therefore concentrating on different applications of beta-glucan products.

Tate & Lyle PLC (UK), Kerry Group plc (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), Lesaffre (France), Kemin Industries (US), Angel Yeast Co. Ltd (China), Lallemand (Canada), Associated British Foods Plc (UK), Bigrigin (Brazil), Ceapro, Inc. (Canada), NutriScience Innovations, LLC (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany) are the key players in the beta-glucan market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=5191796

Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting

Related Reports:

Feed Yeast Market by Type (Yeast Derivatives, Probiotic Yeast, Brewer's Yeast, and Specialty Yeast), Livestock (Ruminants, Swine, Poultry, Aquatic Animals, Pets and Equine), Genus , and Region - Global Forecast to 2025

Specialty Yeast Market by Type (Yeast Extracts, Yeast Autolysates, Yeast Beta-glucan, and Other Yeast Derivatives), Species (Saccharomyces Cerevisiae, Pichia Pastoris, Kluyveromyces), Application and Region – Global Forecast to 2027

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/beta-glucan-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/beta-glucan.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/beta-glucan-market-worth-800-million-by-2029--exclusive-report-by-marketsandmarkets-302125648.html

SOURCE MarketsandMarkets